Shire (SHPG): FDA Grants Priority Review to Lifitegrast NDA
Tweet Send to a Friend
Shire plc (NASDAQ: SHPG) today announced that the United States Food and Drug Administration (FDA) has accepted for filing the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE